Navigation Links
Thomson Reuters Launches Thomson Pharma KOLexperts(R) to Help the Pharmaceutical Industry Objectively Identify, Verify and Rank Scientific Experts, Product Advocates, Clinical Investigators and Key Opinion Leaders

PHILADELPHIA and LONDON, Oct. 15 /PRNewswire/ -- Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, announced today the launch of Thomson Pharma KOLexperts, a new solution designed to help pharmaceutical organizations identify, verify, and develop productive relationships with key opinion leaders (KOLs) and scientific experts. It is the first solution available to the industry that allows users to rank life sciences KOLs with a range of objective metrics. Designed for scientific expertise identification, Thomson Pharma KOLexperts offers a variety of tools to find experts with specific scientific competencies.

"Leveraging external experts is crucial to the success of drug development today. Our customers increasingly want to build their research, clinical and marketing teams based on objective criteria such as scientific credibility, but lack the information and analysis to do so. We have harnessed Thomson Reuter's long legacy in information aggregation, citation analysis, and scientific expertise to deliver a first-in-class solution to our customers," said Wendy Hamilton, vice president, product strategy, Pharmaceutical and Chemicals Markets, Thomson Reuters. "When designing Thomson Pharma KOLexperts, our objective was to create a life sciences 'Who's Who' of experts that can be leveraged at any point from discovery to market. We utilize trusted data that is skillfully indexed, carefully researched, and always up to date."

Users of Thomson Pharma KOLexperts can search for and view experts in a therapy area of interest, and determine a scientist's ranking at a glance as extrapolated from cited work, research activity, speaking engagements and other promotional or educational efforts. As there is no one ranking system that addresses all priorities and considerations, the customer can adjust the ranking approach directly within the product using simple point and click. The solution brings together the core databases of Thomson Reuters with key external data sources to offer an up-to-the-minute snapshot of an expert's status. It also allows users to identify the scientists recognized as leaders in their therapeutic areas and highlight new and emerging stars.

"In the face of an emerging regulatory environment that demands greater transparency into KOL selection and fair remuneration, objectively identifying KOLs based on scientific merit paves the way for success throughout the drug development and marketing process. Thomson Pharma KOLexperts is the first product to enable the optimal alignment of KOLs with the business strategies of individual life sciences organizations based on science, not subjectivity," added Hamilton.

Thomson Pharma KOLexperts can be adapted to the unique needs of each subscribing company. In addition to the standard product, new types of expert profiles can be created upon demand based on customer request.

For more information, visit:

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to

SOURCE Thomson Reuters
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Thomson Scientific Predicts Nobel Laureates
2. Thomson Scientific Announces BONDplus for Biological Researchers
3. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
4. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
5. Thomson Healthcare Endorsed as Preferred Vendor of Information Products and Services for Virginia Hospitals
6. Thomson Acquires Prous Science
7. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
8. Thomson Scientific Ranks Australian Universities and Research Institutes
9. Thomson Scientific Launches Confessions ... of a User Campaign Asking Are You the New Face of Research?
10. Contract Renewal Extends Thomson Healthcares Long-Standing Relationship with University Hospitals
11. Thomson Healthcare Launches Application That Assesses Physician Performance
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia ... the company,s second affiliate in Latin America . ... ... Farma Colombia ... ...
Breaking Medicine Technology: